Fennec Pharmaceuticals Inc. FENC
NASDAQ · United States · Health Technology
$10.20-0.13 (-1.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | 0.05 | 0.02 | +150.0% | $17.87M | +10.3% | +8.1%$10.94→$11.83 |
| Q1 2026 | 2026-05-14 | 0.01 | -0.02 | +150.0% | — | — | +44.0%$6.77→$9.75 |
| Q4 2025 | 2026-03-24 | -0.10 | 0.04 | -350.0% | — | — | -17.2%$7.45→$6.17 |
| Q3 2025 | 2025-11-13 | -0.02 | -0.08 | +75.0% | — | — | +1.0%$7.78→$7.86 |
| Q4 2024 | 2025-03-10 | -0.06 | -0.13 | +53.8% | — | — | — |
| Q4 2023 | 2024-03-21 | -0.10 | -0.10 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.